Brief.Reports

Determining the Viability of Early : Two Case Reports

Pamela M . D avis, M D Northridjje, C alifornia

First-trimester bleeding demands that an expedient diag­ ported last menstrual period. The implications o f the nosis be made if an ectopic is suspected. In slow rise in the /3-HCG were discussed, and the patient addition, rapid determination of a failed pregnancy or wished the pregnancy terminated if the physicians be­ blighted ovum is often sought to facilitate quick evacu­ lieved it was abnormal. Two days later the /3-HCG was ation of the products of conception. Ultrasonography 17,900. After gynecological consultation, she was tenta­ and quantitative measurement o f the /3-subunit o f human tively scheduled for a (D&C). chorionic gonadatropin (/3-HCG) have raised the expec­ On further consideration, surgery was postponed. A tation that early determination o f fetal viability is possi­ repeat ultrasound 6 days after the initial one revealed no ble. These expectations may be unfounded. This report change: a persistent empty without a fetal presents two cases in which undue reliance on laboratory pole (Figure 1). The evidence pointed to an inevitable interpretations could have led to adverse iatrogenic out­ ; however, the patient’s stable condition and the comes. clinician’s skepticism about the available information prompted further waiting. Two days later, the /3-HCG level was 29,000, and a third ultrasound 13 days after the original one demonstrated a viable intrauterine preg­ Case 1 nancy corresponding to a fetal age o f 8 weeks. The A 28-year-old woman, gravida 6, para 1, with a history patient subsequently gave birth to a normal male infant at of 3 therapeutic and 1 spontaneous abortion, term. presented to the office 6 5/7 weeks after her last menstrual period. She had a history o f occasional irregular periods and was not using contraception. Her examination was unremarkable except for obesity. A qualitative serum Case 2 /3-HCG pregnancy test was positive. Two weeks later the A 35-year-old woman, with an obstetric history identical patient reported pain on the left side o f her pelvis. The to the patient in case 1, was seen 6 V2 weeks after her last felt soft and enlarged, and the adnexa were nor­ menstrual period to confirm a possible pregnancy. She mal. A pelvic ultrasonogram showed an echogenic ring in had a history o f regular periods and was trying to con­ the center o f the uterus, consistent with an atypical ceive; therefore, she was not using contraception. The gestational sac, and a 5-cm cyst on her right ovary. The patient began spotting that day. Examination revealed a radiologist reported this as most consistent with a drop o f blood on a closed cervix, a soft fundus, and blighted ovum, but concluded that abnormal gestation or normal adnexa. Continued spotting and fears arising early normal gestation was possible. At the time of the from a recent prompted the patient to re­ test, the patient’s /3-HCG level was 9100 mlU/mL, and quest an ultrasound examination. At 7 2h weeks a pelvic 48 hours later it was 14,300 mlU/mL. The patient re­ ultrasound examination was obtained. It indicated a ges­ membered some “red discharge” 1 month after her re- tational sac o f 22 mm mean diameter, which corre­ sponded to an age o f 7 weeks. No fetal pole was visual­ ized, however, and the possibility of a blighted ovum or Submitted, r ev ised Jum 27y 1991. an incomplete abortion was raised (Figure 2). One week trom the Northridge Family Practice Presidency Program. Requests fo r reprints should later the physical examination was unchanged. The pa­ be addressed to Pam ela M . D ans, M D , Northridge Family Practice Residency Pro- gram, 18406 Roscoe Blvd, Northridge, CA 91325. tient’s /3-HCG level that day (82/z weeks) was 123,000

® 1991 Appleton & Lange ISSN 0094-3509 The Journal of Family Practice, Vol. 33, No. 4, 1991 401 Pregnancy Viability Davis

Figure 3. Pelvic ultrasonogram at 9 weeks after last menstrual Figure 1. Pelvic ultrasonogram 7 weeks after last menstrual period demonstrates a viable 972-week fetus (case 2). period (case 1). Note the echogenic ring in the uterus without a fetal pole, consistent with a blighted ovum. Discussion

Ultrasonic demonstration o f cardiac activity by 9 weeks is mIU/mL; 48 hours later the level was 50,840 mlU/mL. an established test o f fetal viability.1 Earlier confirmation The patient was informed of the significance of the is now frequently possible with vaginal probe ultraso­ results and advised to repeat the tests in 1 week. The nography. Measurements o f /3-HCG are most predictive following week the patient’s /3-HCG level was 710,000 before 6 weeks.2'3 It is in the 6-to-9-weeks stage, when mIU/mL, and a second ultrasound examination 2V i bleeding often occurs, that prognosis is difficult. weeks after the initial study demonstrated a viable 9V2- Single samples o f (3-H C G are not reliable predictors week fetus (Figure 3). The patient gave birth to a normal o f fetal viability4-5; therefore, serial measurements of female infant at 42 weeks. /3-HCG arc advocated.2’6-12 The character o f /3-HCG levels to rise in normal pregnancy has led to the use of the /3-HCG “doubling time” to establish viability. Measured doubling times vary from 1.4 to 5 days and increase with .6’7 The need to translate these data into clinical practice has resulted in the establishment of 48 hours as the normal doubling time in early pregnan-

Cy.8, 13— is The usc 0f doubling time is often faulty, how­ ever, owing to its relationship to the gestational age, which may be in error. One difficulty in establishing pregnancy viability early lies in differentiating the blighted ovum (“empty' sac”) from the similar appearing misdated early gestation. The pelvic ultrasound cannot distinguish between the two before 8 weeks’ gestation.16’17 Therefore, the diag­ nosis o f a blighted ovum requires two or three serial ultrasound examinations. Certain sonographic findings arc proposed as measures o f nonviability. The only indi­ cator universally agreed upon is that a sac 2.5 mL in size without a fetal pole is the threshold o f nonviability. 15~21 Figure 2. Pelvic ultrasonogram at 7 weeks after last menstrual The vaginal probe ultrasound, which is now available, period (case 2). No fetal pole is visualized. offers earlier confirmation o f viability. Additional expe- continued on page 404

402 The Journal of Family Practice, Vol. 33, No. 4, 1991 Pregnancy Viability Davis continued from page 402

rience is necessary to see if it eliminates the uncertainty in references in the literature to possible complications of a identifying a blighted ovum. delayed expulsion of a spontaneous abortion (maternal The use o f both serum /3T ICG levels and ultrasono­ infection, hemorrhage, and anxiety) are not equivalent to grams helps to eliminate the uncertainty. Between 6 and the known morbidities of an . 16’22,28 9 weeks, the use o f /3-HCG can be helpful with an If the exclusion o f a clinically suspected extrauterine inconclusive ultrasonogram and can predict abortion in pregnancy can be made by sonography or serology, do 95% of cases.2’3’22 Jouppilla et al1 reported, however, the other diagnostic possibilities require proof in an that the /3-HCG level and gestational sac diameter were urgent manner? The cases presented here suggest that usually normal between 6 and 9 weeks of gestation, even actions to terminate a potentially nonviable pregnancy in pregnancies that later aborted.1 Nybcrg et al23-24 con­ based on the available laboratory and radiographic data cluded that when ultrasound findings are uncertain, a would have led to the unwarranted destruction of two disproportionately low /3-HCG level is supportive evi­ healthy fetuses. dence for an abnormal pregnancy, and serial /3-HCG levels complement ultrasound predictions.25’26 These K ey words. Fetal viability; gonadotropins, chori­ studies point out that normal values do not guarantee onic; ultrasonic diagnosis; pregnancy outcome. future viability, and that abnormal values usually portend a poor outcome, but not with complete certainty. References Widespread recommendations from the family prac­ tice and literature encourage the use of a simple 1. Jouppilla P, Huhtaniemi I, Herva R, Puroinen O. Correlation of human chorionic gonadotropin in early pregnancy failure with size 48-hour doubling time standard without emphasis on its o f gestational sac and placental histology'. Obstet Gynecol 1984' limitations.8’13’14 Thus, in case 1, the radiologist’s origi­ 63:5 3 7 -4 2 . nal ultrasonogram interpretation of “most consistent 2. Batzer F, Weiner S, Corson S, et al. Landmarks during the first forty-two days of gestation demonstrated by the /i-subunit of with a blighted ovum,” (confirmed 1 week later by a “no human chorionic gonadotropin and ultrasound. Am J Obstet change” reading) was “substantiated” by the failure o f Gynecol 1983; 146:973-9. /3-HCG levels to double appropriately. The difficulties 3. Gerhard I, Runnebaum B. Predictive value o f hormone determi­ nations in the first half of pregnancy. Eur J Obstet Gynecol Reprod encountered in case 2 might have been avoided when the Biol 1984; 17:1-17. original inconclusive ultrasonogram, again reading pos­ 4. Jouppilla P, Tapanainen J, Huhtaniemi I. Plasma HCG levels in sible blighted ovum, was compared with the initial patients with bleeding in the first and second trimesters of preg­ nancy. Br J Obstet Gynaecol 1979; 8 6 :343-9. /3-HCG level o f 120,000 mlU/mL. Instead, the serial 5. Scheveditsch M, Dubin N, Jones G, Wentz A. Hormonal consid­ imperative was obeyed in search of 48-hour doubling, erations in early normal pregnancy and blighted ovum syndrome, and a large drop in value (still unexplained) nearly initi­ Fcrtil Steril 1979; 31:252-7. 6. Cartwright P, DiPietro D. Ectopic pregnancy: changes in serum ated evacuation of the uterus. human chorionic gonadotropin concentration. Obstet Gynecol Do the current techniques used to establish first 1984; 63:76-80. trimester viability justify active intervention when fetal 7. Pittaway D, Reisch R, Colston A. Doubling times of human chorionic gonadotropin increase in early viable intrauterine preg­ demise is suspected? Levels o f /3-HCG vary widely as nancies. Am J Obstet Gynecol 1985; 152:299-302. previously discussed, and the practitioner cannot forget 8. Kadar N, Caldwell B, Romero R. A method o f screening for the human variables intrinsic to a laboratory test: speci­ ectopic pregnancy and its indications. Obstet Gynecol 1981; 58: 162-6. men collection, sampling, testing quality, and communi­ 9. Braunstein G, Karow W, Gentry W, et al. First-trimester chorionic cating results. The ultrasonogram’s scope and resolution gonadotropin measurements as an aid in the diagnosis of early has magnified in the last decade, but is also subject to pregnancy disorders. Am J Obstet Gynecol 1978; 131:25-32. 10. Lagrew D, Wilson E, Jawad M. Determination of gestational age human skill and experience. The literature and the com­ by serum concentrations o f human chorionic gonadotropin. munity experience suggest that the confidence placed in Obstet Gynecol 1983; 61:37-40. both ultrasonography and serum /3-HCG levels may be 11. Kadar N, Devore G, Romero R. Discriminatory' HCG zone: its use in the sonographic evaluation for ectopic pregnancy. Obstet greater than the accuracy of the tests warrants. The Gynecol 1981; 58:156-61. physician can be misled in using test results as absolutes 12. Batzer F, Schlaff S, Goldfarb A, Corson S. Serial /3-subunit human without seriously examining their potential fallibility. chorionic gonadotropin doubling time as a prognosticator of preg­ nancy outcome in an infertile population. Fertil Steril 1981; 35: Both techniques have proved invaluable for managing 307-12. patients with suspected ectopic pregnancy. This poten­ 13. Leach R , Oty S. Management o f ectopic pregnancy. Am Fam tially lethal condition makes their margins o f error ac­ Physician 1990; 4 1 :1215-22. 14. Deutchman M. The problematic first-trimester pregnancy. Am ceptable. The potential morbidity of awaiting spontane­ Fam Physician 1989; 39:185-98. ous miscarriage of nonviable has not been 15. Coleman B, Arger P. Ultrasound in early pregnancy complications. defined, however, nor can it be measured against the Clin Obstet Gy'necol 1988; 31 :3 -1 8 . 16. Robinson H. The diagnosis o f early pregnancy failure by sonar. Br consequences of terminating a viable fetus. The cursory J Obstet Gynaecol 1975; 82:849-57.

4 04 The Journal of Family Practice, Vol. 33, No. 4, 1991 P re g n a n cy Viability

17. Ping S. Prognostic predictions o f threatened abortion. A compar­ ison between real time ultrasound, clinical assessment and urinary human chorionic gonadotropin (HCG). Aust N Z J Obstet Gy­ naecol 1983; 23:99-102. 18. Stabile I, Campbell S, Grudzinskas J. Ultrasonic assessment of complications during first trimester o f pregnancy'. Lancet 1987; 1:1237—40. 19. Mantoni M. Ultrasound signs in threatened abortion and their prognostic significance. Obstet Gynecol 1985; 65:471-5. 20. Nyberg D, Laing F, Filly R. Threatened abortion: sonographic distinction o f normal and abnormal gestation sacs. Radiology 1986; 158:397-^00. 21. Bernard K, Cooperberg P. Sonographic differentiation between blighted ovum and early viable pregnancy. AJR 1985; 144:597- 602. 22. Hertz J. Diagnostic procedures in threatened abortion. Obstet Gynecol 1984; 64 :2 2 3 -9 . 23. Nyberg D, Filly R, Duarte Filho D, et al. Abnormal pregnancy: early diagnosis by US and serum chorionic gonadotropin levels. Radiology 1986; 158:393-6. 24. Nyberg D, Filly R , Mahony B, et al. Early gestation: correlation of HCG levels and sonographic identification. AJR 1985; 144: 951-4. 25. Dessaive R , de Hertogh R, Thomas K. Correlation between hor­ monal levels and ultrasound in patients with threatened abortion. Gynecol Obstet Invest 1982; 14:65-78. 26. Eriksen B, Eck-Nes S. Prognostic value o f ultrasound, HCG and progesterone in threatened abortion. J Clin Ultrasound 1986; 14:3-9. 27. Jouppilla P, Huhtaniemi I, Tapanainen J. Early pregnancy failure: study by ultrasonic and hormonal methods. Obstet Gynecol 1980; 55:42-7. 28. Jouppilla P, Herva R. Study o f blighted ovum by ultrasonic and histopathologic methods. Obstet Gynecol 1980; 55:574—8.

The Journal of Family Practice, Vol. 33, No. 4, 1991 © SmithKline Beecham , 1990